Krka Sverige AB has been present on the Nordic markets since 2005. Now, it is one of the leading generic pharmaceutical companies.

Cardiology, gastroenterology and the central nervous system are the major therapeutic areas in which we develop our portfolio of generic medications. 

Quality, safety and efficacy are the main priorities at Krka. A vertically integrated business model ensures control of the whole process, from the development of raw materials to manufacturing and the finished products.

We bring guaranteed stability and security to our clients due to our mostly 70 years of expertise and total control over the production of every single Krka product.  

Krka Sverige AB

Göta Ark 175 (postal address) Medborgarplatsen 25 (visiting address)
118 72 Stockholm